VMAT2 Inhibitors: Valbenazine (Ingrezza) and Deutetrabenazine (Austedo)
From PsychRounds: The Psychiatry Podcast · · 17 min
This plays from the publisher's own server. We do not host a copy.
Not rated yet
Description
Welcome back! Today we are featuring the two FDA-approved medications for tardive dyskinesia, the VMAT2 inhibitors Valbenazine (Ingrezza) and Deutetrabenazine (Austedo).
References:
https://pubmed.ncbi.nlm.nih.gov/41626799/
Back to PsychRounds: The Psychiatry Podcast · Report a problem